[1]
|
Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249.
https://doi.org/10.3322/caac.21660
|
[2]
|
Katai, H., Ishikawa, T., Akazawa, K., et al. (2018) Five-Year Survival Analysis of Surgically Resected Gastric Cancer Cases in Japan: A Retrospective Analysis of More than 100,000 Patients from the Nationwide Registry of the Japanese Gastric Cancer Association (2001-2007). Gastric Cancer, 21, 144-154. https://doi.org/10.1007/s10120-017-0716-7
|
[3]
|
Gill, R.S., Al-Adra, D.P., Nagendran, J., et al. (2011) Treatment of Gastric Cancer with Peritoneal Carcinomatosis by Cytoreductive Surgery and HIPEC: A Systematic Review of Sur-vival, Mortality, and Morbidity. Journal of Surgical Oncology, 104, 692-698. https://doi.org/10.1002/jso.22017
|
[4]
|
Zhao, L., Jiang, L., He, L., et al. (2019) Identification of a Novel Cell Cy-cle-Related Gene Signature Predicting Survival in Patients with Gastric Cancer. Journal of Cellular Physiology, 234, 6350-6360.
https://doi.org/10.1002/jcp.27365
|
[5]
|
Karimi, P., Islami, F., Anandasabapathy, S., et al. (2014) Gastric Cancer: Descriptive Epidemiology, Risk Factors, Screening, and Prevention. Cancer Epidemiology, Biomarkers & Prevention, 23, 700-713.
https://doi.org/10.1158/1055-9965.EPI-13-1057
|
[6]
|
Goodwin, G.H. and Johns, E. (1973) Isolation and Charac-terisation of Two Calf-Thymus Chromatin Non-Histone Proteins with High Contents of Acidic And Basic Amino Acids. European Journal of Biochemistry, 40, 215-219.
https://doi.org/10.1111/j.1432-1033.1973.tb03188.x
|
[7]
|
Goodwin, G.H., Sanders, C. and Johns, E. (1973) A New Group of Chromatin-Associated Proteins with a High Content of Acidic and Basic Amino Acids. European Jour-nal of Biochemistry, 38, 14-19.
https://doi.org/10.1111/j.1432-1033.1973.tb03026.x
|
[8]
|
Kang, R., Chen, R., Zhang, Q., et al. (2014) HMGB1 in Health and Disease. Molecular Aspects of Medicine, 40, 1-116.
https://doi.org/10.1016/j.mam.2014.05.001
|
[9]
|
Yang, H., Liu, H., Zeng, Q., et al. (2019) Inhibition of HMGB1/RAGE-Mediated Endocytosis by HMGB1 Antagonist Box A, Anti-HMGB1 Antibodies, and Cholinergic Agonists Suppresses Inflammation. Molecular Medicine, 25, 13.
https://doi.org/10.1186/s10020-019-0081-6
|
[10]
|
Hou, C., Zhao, H., Liu, L., et al. (2011) High Mobility Group Protein B1 (HMGB1) in Asthma: Comparison of Patients with Chronic Obstructive Pulmonary Disease and Healthy Controls. Molecular Medicine, 17, 807-815.
https://doi.org/10.2119/molmed.2010.00173
|
[11]
|
Hayden, M.S. and Ghosh, S. (2008) Shared Principles in NF-κB Signaling. Cell, 132, 344-362.
https://doi.org/10.1016/j.cell.2008.01.020
|
[12]
|
Nixon, C.C., Mavigner, M., Sampey, G.C., et al. (2020) Systemic HIV and SIV Latency Reversal via Non-Canonical NF-κB Signalling in Vivo. Nature, 578, 160-165. https://doi.org/10.1038/s41586-020-1951-3
|
[13]
|
Barnabei, L., Laplantine, E., Mbongo, W., et al. (2021) NF-κB: At the Borders of Autoimmunity and Inflammation. Frontiers in Immunology, 12, Article ID: 716469. https://doi.org/10.3389/fimmu.2021.716469
|
[14]
|
Asavarut, P., Zhao, H., Gu, J., et al. (2013) The Role of HMGB1 in Inflammation-Mediated Organ Injury. Acta Anaesthesiologica Taiwanica, 51, 28-33. https://doi.org/10.1016/j.aat.2013.03.007
|
[15]
|
Nogueira-Machado, J.A. and de Oliveira Volpe, C.M. (2012) HMGB-1 as a Target for Inflammation Controlling. Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, 6, 201-209.
https://doi.org/10.2174/187221412802481784
|
[16]
|
Teiten, M.-H., Gaigneaux, A., Chateauvieux, S., et al. (2012) Identification of Differentially Expressed Proteins in Curcumin-Treated Prostate Cancer Cell Lines. Omics, 16, 289-300. https://doi.org/10.1089/omi.2011.0136
|
[17]
|
Chen, J., Xi, B., Zhao, Y., et al. (2012) High-Mobility Group Protein B1 (HMGB1) Is a Novel Biomarker for Human Ovarian Cancer. Elsevier, Amsterdam. https://doi.org/10.1016/j.ygyno.2012.03.051
|
[18]
|
Kostova, N., Zlateva, S., Ugrinova, I., et al. (2010) The Expres-sion of HMGB1 Protein and Its Receptor RAGE in Human Malignant Tumors. Molecular and Cellular Biochemistry, 337, 251-258.
https://doi.org/10.1007/s11010-009-0305-0
|
[19]
|
Sterenczak, K.A., Joetzke, A.E., Willenbrock, S., et al. (2010) High-Mobility Group B1 (HMGB1) and Receptor for Advanced Glycation End-Products (RAGE) Expression in Canine Lymphoma. Anticancer Research, 30, 5043-5048.
|
[20]
|
Choi, J., Lee, M.K., Oh, K.H., et al. (2011) Interaction Effect between the Receptor for Advanced Glycation end Products (RAGE) and High-Mobility Group Box-1 (HMGB-1) for the Migration of a Squamous Cell Carcinoma Cell Line. Tumori, 97, 196-202. https://doi.org/10.1177/030089161109700211
|
[21]
|
Liu, Y., Xie, C., Zhang, X., et al. (2010) Elevated Expression of HMGB1 in Squamous-Cell Carcinoma of the Head and Neck and Its Clinical Significance. European Journal of Can-cer, 46, 3007-3015.
https://doi.org/10.1016/j.ejca.2010.07.016
|
[22]
|
Yao, X., Zhao, G., Yang, H., et al. (2010) Overexpression of High-Mobility Group Box 1 Correlates with Tumor Progression and Poor Prognosis in Human Colorectal Carcinoma. Journal of Cancer Research and Clinical Oncology, 136, 677-684. https://doi.org/10.1007/s00432-009-0706-1
|
[23]
|
Bonizzi, G. and Karin, M. (2004) The Two NF-κB Activation Pathways and Their Role in Innate and Adaptive Immunity. Trends in Immunology, 25, 280-288. https://doi.org/10.1016/j.it.2004.03.008
|
[24]
|
Luo, J.-L., Kamata, H. and Karin, M. (2005) IKK/NF-κB Signaling: Balancing Life and Death—A New Approach to Cancer Therapy. Journal of Clinical Investigation, 115, 2625-2632. https://doi.org/10.1172/JCI26322
|
[25]
|
Yu, H., Lin, L., Zhang, Z., et al. (2020) Targeting NF-κB Pathway for the Therapy of Diseases: Mechanism and Clinical Study. Signal Transduction and Targeted Therapy, 5, 209. https://doi.org/10.1038/s41392-020-00312-6
|
[26]
|
Song, K. and Li, S. (2021) The Role of Ubiquitination in NF-κB Signaling during Virus Infection. Viruses, 13, 145.
https://doi.org/10.3390/v13020145
|
[27]
|
Adamzik, M., Schäfer, S., Frey, U.H., et al. (2013) The NFKB1 Promoter Polymorphism (−94ins/delATTG) Alters Nuclear Translocation of NF-κB1 in Monocytes after Lipopolysaccharide Stimulation and Is Associated with Increased Mortality in Sepsis. Anesthesiology, 118, 123-133. https://doi.org/10.1097/ALN.0b013e318277a652
|
[28]
|
Yang, Y., Wang, J., Yang, Q., et al. (2014) Shikonin Inhib-its the Lipopolysaccharide-Induced Release of HMGB1 in RAW264.7 Cells via IFN and NF-κB Signaling Pathways. International Immunopharmacology, 19, 81-87.
https://doi.org/10.1016/j.intimp.2014.01.003
|
[29]
|
Bank, S., Skytt, A.P., Burisch, J., et al. (2014) Polymorphisms in the Inflammatory Pathway Genes TLR2, TLR4, TLR9, LY96, NFKBIA, NFKB1, TNFA, TNFRSF1A, IL6R, IL10, IL23R, PTPN22, and PPARG Are Associated with Susceptibility of Inflammatory Bowel Disease in a Danish Cohort. PLOS ONE, 9, e98815.
https://doi.org/10.1371/journal.pone.0098815
|
[30]
|
Perkins, N. (2012) The Diverse and Complex Roles of NF-κB Subunits in Cancer. Nature Reviews Cancer, 12, 121-132. https://doi.org/10.1038/nrc3204
|
[31]
|
张惠湘, 李鲲, 钟慧军. NFKB1基因启动子区插入/缺失多态性与卵巢上皮性癌的相关性[J]. 宁夏医科大学学报, 2013, 35(3): 296-298.
|
[32]
|
Zhao, X., Li, L., Yuan, S., et al. (2021) SPIB Acts as a Tumor Suppressor by Activating the NF-κB and JNK Signaling Pathways through MAP4K1 in Colorectal Cancer Cells. Cell Signaling, 88, Article ID: 110148.
https://doi.org/10.1016/j.cellsig.2021.110148
|
[33]
|
Arisawa, T., Tahara, T., Shiroeda, H., et al. (2013) Functional Promoter Polymorphisms of NFKB1 Influence Susceptibility to the Diffuse Type of Gastric Cancer. Oncology Reports, 30, 3013-3019. https://doi.org/10.3892/or.2013.2768
|
[34]
|
Liu, J.-Y., Jiang, L., He, T., et al. (2019) NETO2 Pro-motes Invasion and Metastasis of Gastric Cancer Cells via Activation of PI3K/Akt/NF-κB/Snail Axis and Predicts Out-come of the Patients. Cell Death & Disease, 10, Article No. 162.
https://doi.org/10.1038/s41419-019-1388-5
|
[35]
|
Xu, B., Gan, C.-X., Chen, S.-S., et al. (2020) BMSC-Derived Exosomes Alleviate Smoke Inhalation Lung Injury through Blockade of the HMGB1/NF-κB Pathway. Life Sciences, 257, Article ID: 118042.
https://doi.org/10.1016/j.lfs.2020.118042
|
[36]
|
Wang, Y., Shang, G., Wang, W., et al. (2020) Magnoflorine Inhibits the Malignant Phenotypes and Increases Cisplatin Sensitivity of Osteosarcoma Cells via Regulating miR-410-3p/HMGB1/NF-κB Pathway. Life Sciences, 256, Article ID: 117967. https://doi.org/10.1016/j.lfs.2020.117967
|
[37]
|
Zhou, J., Chen, X., Gilvary, D.L., et al. (2015) HMGB1 Induction of Clusterin Creates a Chemoresistant Niche in Human Prostate Tumor Cells. Scientific Reports, 5, Article No. 15085. https://doi.org/10.1038/srep15085
|
[38]
|
Zhang, J., Shao, S., Han, D., et al. (2018) High Mobility Group Box 1 Promotes the Epithelial-to-Mesenchymal Transition in Prostate Cancer PC3 Cells via the RAGE/NF-κB Signaling Path-way. International Journal of Oncology, 53, 659-671. https://doi.org/10.3892/ijo.2018.4420
|
[39]
|
Liu, Y., Yan, W., Tohme, S., et al. (2015) Hypoxia Induced HMGB1 and Mitochondrial DNA Interactions Mediate Tumor Growth in Hepatocellular Carcinoma through Toll-Like Receptor 9. Journal of Hepatology, 63, 114-121.
https://doi.org/10.1016/j.jhep.2015.02.009
|